tiprankstipranks
Trending News
More News >
Ligand Pharma (LGND)
NASDAQ:LGND
US Market

Ligand Pharma (LGND) Technical Analysis

Compare
808 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
3Neutral
7Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Ligand Pharma’s (LGND) Moving Averages Convergence Divergence (MACD) indicator is -0.57, suggesting Ligand Pharma is a Sell.
Ligand Pharma’s (LGND) 20-Day exponential moving average is 103.62, while Ligand Pharma’s (LGND) share price is $105.99, making it a Buy.
Ligand Pharma’s (LGND) 50-Day exponential moving average is 105.36, while Ligand Pharma’s (LGND) share price is $105.99, making it a Buy.

Ligand Pharma (LGND) Pivot Points

Jun 07, 2025, 07:29 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
101.11
101.81
102.99
103.69
104.87
105.57
106.75
Fibonacci
101.81
102.52
102.97
103.69
104.40
104.85
105.57
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ligand Pharma (LGND) Moving Averages

Jun 07, 2025, 07:29 PM
Period
Simple
Exponential
MA5
103.59Buy
104.04Buy
MA10
102.45Buy
103.40Buy
MA20
103.40Buy
103.62Buy
MA50
104.71Buy
105.36Buy
MA100
109.38Sell
107.15Sell
MA200
109.59Sell
105.96Buy
Ligand Pharma’s (LGND) 10-Day exponential moving average is 103.40, while Ligand Pharma’s (LGND) share price is $105.99, making it a Buy.
Ligand Pharma’s (LGND) 100-Day exponential moving average is 107.15, while Ligand Pharma’s (LGND) share price is $105.99, making it a Sell.
Ligand Pharma’s (LGND) stock price is $105.99 and Ligand Pharma’s (LGND) 50-day simple moving average is 104.71, creating a Buy signal.
Ligand Pharma’s (LGND) stock price is $105.99 and Ligand Pharma’s (LGND) 100-day simple moving average is 109.38, creating a Sell signal.
Ligand Pharma’s (LGND) stock price is $105.99 and Ligand Pharma’s (LGND) 200-day simple moving average is 109.59, creating a Sell signal.

Ligand Pharma (LGND) Technical Indicators

Jun 07, 2025, 07:29 PM
Name
Value
Implied Action
RSI (14)
56.12
Neutral
STOCH (9,6)
94.39
Sell
STOCHRSI (14)
82.41
Sell
MACD (12,26)
-0.57
Sell
ADX (14)
19.67
Buy
Williams %R
-9.09
Sell
CCI (14)
89.57
Neutral
ATR (14)
3.28
-
Ultimate Oscillator
63.80
Neutral
ROC
1.39
Buy
Ligand Pharma’s (LGND) Relative Strength Index (RSI) is 56.12, creating a Neutral signal.
Ligand Pharma’s (LGND) Trend Strength Indicator (ADX) is 19.67, creating a Buy signal.
Ligand Pharma’s (LGND) Commodity Channel Index (CCI) is 89.57, creating a Neutral signal.
Ligand Pharma’s (LGND) Price Rate of Change (ROC) is 1.39, creating a Buy signal.

FAQ

Is LGND a Buy, Hold, or Sell?
Based on LGND’s technical indicators, LGND is a Buy.
    What is LGND’s RSI (14)?
    LGND’s RSI (14) is 56.12, which suggests LGND is a Neutral.
      What is LGND’s MACD?
      LGND’s MACD is -0.57, which suggests LGND is a Sell.
        What is LGND’s 5-day moving average?
        LGND’s 5-day moving average is 103.59, which suggests LGND is a Buy.
          What is LGND’s 20-day moving average?
          LGND 20-day moving average is 103.40, which suggests LGND is a Buy.
            What is LGND’s 50-day moving average?
            LGND’s 50-day moving average is 104.71, which suggests LGND is a Buy.
              What is LGND’s 200-day moving average?
              LGND’s 200-day moving average is 109.59, which suggests LGND is a Sell.
                What is LGND’s Williams % R (14)?
                LGND’s Williams % R (14) is -9.09, which suggests LGND is a Sell.
                  What is LGND’s CCI (14)?
                  LGND’s CCI (14) is 89.57, which suggests LGND is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis